ACAD (STOCKS)
Acadia Pharmaceuticals Inc.
$22.240000
-0.460000 (-2.03%)
Prev close: $22.700000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Catherine Owen Adams
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $3,762.61M
- Employees
- 654
- P/E (TTM)
- 14.61
- P/B (TTM)
- 4.19
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
5
Strong Buy
13
Buy
7
Hold
1
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$0.42 | $0.15 | +0.2690 | +178.15% |
|
Jun 2025 (Q2)
|
$0.16 | $0.14 | +0.0202 | +14.45% |
|
Mar 2025 (Q1)
|
$0.11 | $0.11 | -0.0036 | -3.17% |
|
Dec 2024 (Q4)
|
$-0.02 | $0.22 | -0.2404 | -109.07% |
Financial Statements
| Assets | $1.33B |
| Current Assets | $1.08B |
| Inventory | $105.99M |
| Prepaid Expenses | $60.87M |
| Other Current Assets | $909.57M |
| Noncurrent Assets | $254.35M |
| Fixed Assets | $3.71M |
| Other Non-current Assets | $250.64M |
| Liabilities | $413.50M |
| Current Liabilities | $356.58M |
| Accounts Payable | $21.75M |
| Wages | $37.81M |
| Other Current Liabilities | $297.02M |
| Noncurrent Liabilities | $56.92M |
| Equity | $917.27M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $917.27M |
| Liabilities And Equity | $1.33B |